Rischin, D., Migden, M.R., Chang, A.L.S. and al., E. 2018. Primary Analysis of Phase 2 Results for Cemiplimab, a Human Monoclonal Anti-PD-1, in Patients with Metastatic Cutaneous Squamous Cell Carcinoma. SKIN The Journal of Cutaneous Medicine. 2, (Dec. 2018), S79. DOI:https://doi.org/10.25251/skin.2.supp.79.